{"id":355772,"date":"2025-08-29T02:46:08","date_gmt":"2025-08-29T02:46:08","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-haemonetics-corporation\/"},"modified":"2025-08-29T02:46:08","modified_gmt":"2025-08-29T02:46:08","slug":"how-to-buy-haemonetics-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","title":{"rendered":"How to buy Haemonetics Corporation (HAE) shares &#8211; Investment in Haemonetics Corporation (HAE) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-355772","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Haemonetics Corporation (HAE) Shares - Investment in Haemonetics Corporation (HAE) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Haemonetics Corporation (HAE) Shares - Investment in Haemonetics Corporation (HAE) Stock"},"description":"Learn how to buy Haemonetics Corporation (HAE) shares and invest in this medical technology leader. Discover current price, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Haemonetics Corporation (HAE) shares and invest in this medical technology leader. Discover current price, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in a company that's literally saving lives while potentially growing your wealth? Haemonetics Corporation (HAE) sits at the fascinating intersection of medical innovation and investment opportunity. This isn't just another tech stock\u2014it's a company that helps hospitals and blood centers operate more efficiently while improving patient outcomes. Let's explore why HAE deserves your attention and how you can become part of their life-saving mission.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a company that's literally saving lives while potentially growing your wealth? Haemonetics Corporation (HAE) sits at the fascinating intersection of medical innovation and investment opportunity. This isn't just another tech stock\u2014it's a company that helps hospitals and blood centers operate more efficiently while improving patient outcomes. Let's explore why HAE deserves your attention and how you can become part of their life-saving mission."},"body_html":"<h2>\ud83d\udcc8 HAE Stock: Current Price and Critical Dates<\/h2> <p>As of August 29, 2025, Haemonetics Corporation (HAE) trades at <strong>$55.03<\/strong> on the NYSE. But here's what really matters: <strong>November 6, 2025<\/strong> is your next big date to watch. That's when the company releases its next earnings report, and history shows these events can move the needle significantly.<\/p> <h3>How Earnings Reports Impact HAE Stock<\/h3> <p>Looking at recent patterns, HAE has shown some dramatic reactions to financial news. The most recent Q1 2026 earnings on August 7, 2025, created quite a stir despite beating expectations. The company posted earnings of <strong>$1.10 per share<\/strong>, surpassing the $1.01 consensus estimate by $0.09, while revenue of $321.39 million also exceeded expectations despite a 4.4% year-over-year decline<a href=\"https:\/\/www.perplexity.ai\/finance\/HAE\/history\">(Stock Analysis)<\/a>.<\/p> <p>What's fascinating is the market's reaction: a <strong>21.85% pre-market drop<\/strong> after these results, pushing the stock near its 52-week low. This disconnect between solid fundamentals and market sentiment creates potential opportunities for savvy investors.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Purpose<\/h2> <p>HAE's recent performance reads like a medical drama\u2014full of twists, turns, and unexpected developments:<\/p> <p><strong>January-March 2025<\/strong>: The stock built momentum, climbing from the $60s range as the company continued executing its strategic vision in plasma technology.<\/p> <p><strong>April-June 2025<\/strong>: HAE reached impressive heights, touching nearly <strong>$80 per share<\/strong> in early July as investor confidence grew in their medical technology innovations.<\/p> <p><strong>July-August 2025<\/strong>: The dramatic pullback occurred, with the stock retreating to current levels around $55. This represents approximately a <strong>30% decline<\/strong> from summer peaks<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/\">(Stock Analysis)<\/a>.<\/p> <p>Why the volatility? Several factors contributed: portfolio transition risks, margin pressures, and broader market uncertainties affecting healthcare stocks. But here's the key insight\u2014the company's fundamentals remained strong throughout this rollercoaster ride.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Growth Trajectory<\/h2> <p>Analysts remain overwhelmingly bullish on HAE's long-term prospects. Here's what the experts see coming:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: $64-68 range (16-23% upside from current levels)<\/li> <li><strong>2026 Forecast<\/strong>: $86-94 average target (56-70% potential growth)<\/li> <li><strong>2028 Projection<\/strong>: $95-110 range as plasma technology adoption accelerates<\/li> <li><strong>2030 Outlook<\/strong>: $100-116 potential as global healthcare demands increase<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/forecast\/\">(Analyst Consensus)<\/a><\/li> <\/ul> <p>The consensus? <strong>STRONG BUY<\/strong>. Nine analysts covering the stock maintain an average price target of <strong>$103.56<\/strong>, representing approximately 88% upside potential from current levels<a href=\"https:\/\/stocksguide.com\/en\/forecast\/Haemonetics-Corporation-US4050241003\">(StocksGuide)<\/a>.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Revenue Guidance<\/strong>: Company expects 3-6% revenue decline for 2026<\/li> <li><strong>Market Concentration<\/strong>: 80% dependency on U.S. plasma donor systems<\/li> <li><strong>Execution Gaps<\/strong>: Transition risks between business segments<\/li> <li><strong>Volatility<\/strong>: Daily price swings averaging 2.71%<a href=\"https:\/\/stockinvest.us\/stock\/HAE\">(StockInvest)<\/a><\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Strong Margins<\/strong>: 16.8% operating margin outperforming peers<\/li> <li><strong>Innovation Leadership<\/strong>: FDA-cleared plasma collection enhancements<\/li> <li><strong>Institutional Confidence<\/strong>: 400%+ stake increases by major investors<\/li> <li><strong>Buyback Program<\/strong>: $150 million share repurchase authorization<a href=\"https:\/\/www.ainvest.com\/news\/haemonetics-hae-dislocated-market-opportunity-earnings-strength-full-year-guidance-2508\/\">(AInvest)<\/a><\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Dollar-Cost Average<\/strong>: Invest fixed amounts regularly rather than timing the market<\/li> <li><strong>Set Price Alerts<\/strong>: Monitor around November 6 earnings for potential entry points<\/li> <li><strong>Research Fundamentals<\/strong>: Understand the plasma technology story behind the stock<\/li> <li><strong>Diversify Appropriately<\/strong>: Keep HAE as part of a balanced healthcare portfolio<\/li> <\/ol> <p>Humorous trader wisdom: \"Trading HAE is like plasma donation\u2014sometimes you feel a pinch, but you're helping save lives while potentially getting paid for it!\"<\/p> <h2>\u2705 How to Buy Haemonetics Corporation (HAE) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NYSE-listed stocks and competitive fees<\/td><\/tr> <tr><td>2<\/td><td>Complete Account Funding<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>3<\/td><td>Search for \"HAE\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>4<\/td><td>Select Order Type<\/td><td>Use limit orders to control your entry price<\/td><\/tr> <tr><td>5<\/td><td>Review and Execute<\/td><td>Double-check order details before confirming<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Makes Sense for Healthcare Stocks<\/h2> <p>For investors interested in companies like Haemonetics, Pocket Option offers several advantages that align perfectly with healthcare sector investing:<\/p> <ul> <li><strong>Minimum Deposit<\/strong>: Just $5 lets you start building positions in medical innovation stocks<\/li> <li><strong>Rapid Verification<\/strong>: Single-document KYC process means you can start trading quickly<\/li> <li><strong>Flexible Withdrawals<\/strong>: 100+ methods including traditional and digital options<\/li> <li><strong>Educational Resources<\/strong>: Access to healthcare sector analysis and market insights<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for investors who want to gradually build positions in promising healthcare companies without committing large sums initially.<\/p> <h2>\ud83c\udf0d Haemonetics in 2025: Medical Technology Leader<\/h2> <p>Haemonetics Corporation stands as a global medical technology innovator with a remarkable story. The company operates across three core segments that touch critical healthcare needs:<\/p> <ul> <li><strong>Plasma Operations<\/strong>: Their NexSys PCS system represents cutting-edge plasma collection technology, recently enhanced with FDA-cleared improvements that reduce procedure times to just 33-38 minutes<a href=\"https:\/\/www.biospace.com\/haemonetics-receives-fda-clearance-for-enhancements-to-nexsys-pcs-plasma-collection-system\">(BioSpace)<\/a>.<\/li> <li><strong>Blood Center Solutions<\/strong>: Helping ensure blood safety and improve operational efficiency for blood collection organizations worldwide.<\/li> <li><strong>Hospital Technologies<\/strong>: Providing hemostasis diagnostics, transfusion management software, and cell salvage systems that improve patient outcomes.<\/li> <\/ul> <p>With over 50 million real-world collections completed on their systems and a presence in approximately 95 countries, Haemonetics has established itself as a trusted partner in healthcare efficiency<a href=\"https:\/\/www.haemonetics.com\/about-us\">(Haemonetics)<\/a>.<\/p> <p><strong>Interesting Fact for 2025<\/strong>: Haemonetics' IMPACT study\u2014one of the largest clinical trials on plasmapheresis\u2014involved 3,443 donors and demonstrated an 8.2% increase in plasma volume collected per donation while maintaining superior safety standards<a href=\"https:\/\/www.stocktitan.net\/news\/HAE\/haemonetics-clinical-study-results-on-a-new-personalized-approach-to-v9whyyljwxi7.html\">(StockTitan)<\/a>. This innovation directly addresses the growing global demand for plasma-derived therapies that treat everything from immune disorders to trauma care.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 HAE Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 29, 2025, Haemonetics Corporation (HAE) trades at <strong>$55.03<\/strong> on the NYSE. But here&#8217;s what really matters: <strong>November 6, 2025<\/strong> is your next big date to watch. That&#8217;s when the company releases its next earnings report, and history shows these events can move the needle significantly.<\/p>\n<h3>How Earnings Reports Impact HAE Stock<\/h3>\n<p>Looking at recent patterns, HAE has shown some dramatic reactions to financial news. The most recent Q1 2026 earnings on August 7, 2025, created quite a stir despite beating expectations. The company posted earnings of <strong>$1.10 per share<\/strong>, surpassing the $1.01 consensus estimate by $0.09, while revenue of $321.39 million also exceeded expectations despite a 4.4% year-over-year decline<a href=\"https:\/\/www.perplexity.ai\/finance\/HAE\/history\">(Stock Analysis)<\/a>.<\/p>\n<p>What&#8217;s fascinating is the market&#8217;s reaction: a <strong>21.85% pre-market drop<\/strong> after these results, pushing the stock near its 52-week low. This disconnect between solid fundamentals and market sentiment creates potential opportunities for savvy investors.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Purpose<\/h2>\n<p>HAE&#8217;s recent performance reads like a medical drama\u2014full of twists, turns, and unexpected developments:<\/p>\n<p><strong>January-March 2025<\/strong>: The stock built momentum, climbing from the $60s range as the company continued executing its strategic vision in plasma technology.<\/p>\n<p><strong>April-June 2025<\/strong>: HAE reached impressive heights, touching nearly <strong>$80 per share<\/strong> in early July as investor confidence grew in their medical technology innovations.<\/p>\n<p><strong>July-August 2025<\/strong>: The dramatic pullback occurred, with the stock retreating to current levels around $55. This represents approximately a <strong>30% decline<\/strong> from summer peaks<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/\">(Stock Analysis)<\/a>.<\/p>\n<p>Why the volatility? Several factors contributed: portfolio transition risks, margin pressures, and broader market uncertainties affecting healthcare stocks. But here&#8217;s the key insight\u2014the company&#8217;s fundamentals remained strong throughout this rollercoaster ride.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Growth Trajectory<\/h2>\n<p>Analysts remain overwhelmingly bullish on HAE&#8217;s long-term prospects. Here&#8217;s what the experts see coming:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: $64-68 range (16-23% upside from current levels)<\/li>\n<li><strong>2026 Forecast<\/strong>: $86-94 average target (56-70% potential growth)<\/li>\n<li><strong>2028 Projection<\/strong>: $95-110 range as plasma technology adoption accelerates<\/li>\n<li><strong>2030 Outlook<\/strong>: $100-116 potential as global healthcare demands increase<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/forecast\/\">(Analyst Consensus)<\/a><\/li>\n<\/ul>\n<p>The consensus? <strong>STRONG BUY<\/strong>. Nine analysts covering the stock maintain an average price target of <strong>$103.56<\/strong>, representing approximately 88% upside potential from current levels<a href=\"https:\/\/stocksguide.com\/en\/forecast\/Haemonetics-Corporation-US4050241003\">(StocksGuide)<\/a>.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Revenue Guidance<\/strong>: Company expects 3-6% revenue decline for 2026<\/li>\n<li><strong>Market Concentration<\/strong>: 80% dependency on U.S. plasma donor systems<\/li>\n<li><strong>Execution Gaps<\/strong>: Transition risks between business segments<\/li>\n<li><strong>Volatility<\/strong>: Daily price swings averaging 2.71%<a href=\"https:\/\/stockinvest.us\/stock\/HAE\">(StockInvest)<\/a><\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Strong Margins<\/strong>: 16.8% operating margin outperforming peers<\/li>\n<li><strong>Innovation Leadership<\/strong>: FDA-cleared plasma collection enhancements<\/li>\n<li><strong>Institutional Confidence<\/strong>: 400%+ stake increases by major investors<\/li>\n<li><strong>Buyback Program<\/strong>: $150 million share repurchase authorization<a href=\"https:\/\/www.ainvest.com\/news\/haemonetics-hae-dislocated-market-opportunity-earnings-strength-full-year-guidance-2508\/\">(AInvest)<\/a><\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Dollar-Cost Average<\/strong>: Invest fixed amounts regularly rather than timing the market<\/li>\n<li><strong>Set Price Alerts<\/strong>: Monitor around November 6 earnings for potential entry points<\/li>\n<li><strong>Research Fundamentals<\/strong>: Understand the plasma technology story behind the stock<\/li>\n<li><strong>Diversify Appropriately<\/strong>: Keep HAE as part of a balanced healthcare portfolio<\/li>\n<\/ol>\n<p>Humorous trader wisdom: &#8220;Trading HAE is like plasma donation\u2014sometimes you feel a pinch, but you&#8217;re helping save lives while potentially getting paid for it!&#8221;<\/p>\n<h2>\u2705 How to Buy Haemonetics Corporation (HAE) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and competitive fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Funding<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search for &#8220;HAE&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders to control your entry price<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and Execute<\/td>\n<td>Double-check order details before confirming<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for Healthcare Stocks<\/h2>\n<p>For investors interested in companies like Haemonetics, Pocket Option offers several advantages that align perfectly with healthcare sector investing:<\/p>\n<ul>\n<li><strong>Minimum Deposit<\/strong>: Just $5 lets you start building positions in medical innovation stocks<\/li>\n<li><strong>Rapid Verification<\/strong>: Single-document KYC process means you can start trading quickly<\/li>\n<li><strong>Flexible Withdrawals<\/strong>: 100+ methods including traditional and digital options<\/li>\n<li><strong>Educational Resources<\/strong>: Access to healthcare sector analysis and market insights<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for investors who want to gradually build positions in promising healthcare companies without committing large sums initially.<\/p>\n<h2>\ud83c\udf0d Haemonetics in 2025: Medical Technology Leader<\/h2>\n<p>Haemonetics Corporation stands as a global medical technology innovator with a remarkable story. The company operates across three core segments that touch critical healthcare needs:<\/p>\n<ul>\n<li><strong>Plasma Operations<\/strong>: Their NexSys PCS system represents cutting-edge plasma collection technology, recently enhanced with FDA-cleared improvements that reduce procedure times to just 33-38 minutes<a href=\"https:\/\/www.biospace.com\/haemonetics-receives-fda-clearance-for-enhancements-to-nexsys-pcs-plasma-collection-system\">(BioSpace)<\/a>.<\/li>\n<li><strong>Blood Center Solutions<\/strong>: Helping ensure blood safety and improve operational efficiency for blood collection organizations worldwide.<\/li>\n<li><strong>Hospital Technologies<\/strong>: Providing hemostasis diagnostics, transfusion management software, and cell salvage systems that improve patient outcomes.<\/li>\n<\/ul>\n<p>With over 50 million real-world collections completed on their systems and a presence in approximately 95 countries, Haemonetics has established itself as a trusted partner in healthcare efficiency<a href=\"https:\/\/www.haemonetics.com\/about-us\">(Haemonetics)<\/a>.<\/p>\n<p><strong>Interesting Fact for 2025<\/strong>: Haemonetics&#8217; IMPACT study\u2014one of the largest clinical trials on plasmapheresis\u2014involved 3,443 donors and demonstrated an 8.2% increase in plasma volume collected per donation while maintaining superior safety standards<a href=\"https:\/\/www.stocktitan.net\/news\/HAE\/haemonetics-clinical-study-results-on-a-new-personalized-approach-to-v9whyyljwxi7.html\">(StockTitan)<\/a>. This innovation directly addresses the growing global demand for plasma-derived therapies that treat everything from immune disorders to trauma care.<\/p>\n"},"faq":[{"question":"What makes Haemonetics different from other medical device companies?","answer":"Haemonetics specializes in end-to-end blood and plasma management solutions, with particular expertise in automated collection systems that improve efficiency and safety simultaneously."},{"question":"How volatile is HAE stock typically?","answer":"HAE exhibits moderate to high volatility, with daily price movements averaging 2.71%. The stock has experienced significant swings around earnings announcements, creating both risks and opportunities."},{"question":"What's the dividend situation for HAE?","answer":"Haemonetics does not currently pay a regular dividend, preferring to reinvest profits into research and development and strategic initiatives to drive long-term growth."},{"question":"How dependent is Haemonetics on the U.S. market?","answer":"The company has significant U.S. exposure with approximately 80% market share in domestic plasma donor management systems, but it also operates globally across 95 countries."},{"question":"What are the main growth drivers for Haemonetics?","answer":"Key growth drivers include increasing global demand for plasma-derived therapies, healthcare efficiency improvements, technological innovations in collection systems, and expansion in international markets."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What makes Haemonetics different from other medical device companies?","answer":"Haemonetics specializes in end-to-end blood and plasma management solutions, with particular expertise in automated collection systems that improve efficiency and safety simultaneously."},{"question":"How volatile is HAE stock typically?","answer":"HAE exhibits moderate to high volatility, with daily price movements averaging 2.71%. The stock has experienced significant swings around earnings announcements, creating both risks and opportunities."},{"question":"What's the dividend situation for HAE?","answer":"Haemonetics does not currently pay a regular dividend, preferring to reinvest profits into research and development and strategic initiatives to drive long-term growth."},{"question":"How dependent is Haemonetics on the U.S. market?","answer":"The company has significant U.S. exposure with approximately 80% market share in domestic plasma donor management systems, but it also operates globally across 95 countries."},{"question":"What are the main growth drivers for Haemonetics?","answer":"Key growth drivers include increasing global demand for plasma-derived therapies, healthcare efficiency improvements, technological innovations in collection systems, and expansion in international markets."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Haemonetics Corporation (HAE) shares - Investment in Haemonetics Corporation (HAE) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Haemonetics Corporation (HAE) shares - Investment in Haemonetics Corporation (HAE) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T02:46:08+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Haemonetics Corporation (HAE) shares &#8211; Investment in Haemonetics Corporation (HAE) stock\",\"datePublished\":\"2025-08-29T02:46:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\",\"name\":\"How to buy Haemonetics Corporation (HAE) shares - Investment in Haemonetics Corporation (HAE) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-29T02:46:08+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Haemonetics Corporation (HAE) shares &#8211; Investment in Haemonetics Corporation (HAE) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Haemonetics Corporation (HAE) shares - Investment in Haemonetics Corporation (HAE) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Haemonetics Corporation (HAE) shares - Investment in Haemonetics Corporation (HAE) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T02:46:08+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Haemonetics Corporation (HAE) shares &#8211; Investment in Haemonetics Corporation (HAE) stock","datePublished":"2025-08-29T02:46:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","name":"How to buy Haemonetics Corporation (HAE) shares - Investment in Haemonetics Corporation (HAE) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-29T02:46:08+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Haemonetics Corporation (HAE) shares &#8211; Investment in Haemonetics Corporation (HAE) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":355781,"slug":"how-to-buy-haemonetics-corporation","post_title":"Comment acheter des actions Haemonetics Corporation (HAE) - Investir dans les actions Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"it_IT":{"locale":"it_IT","id":355780,"slug":"how-to-buy-haemonetics-corporation","post_title":"Come acquistare azioni Haemonetics Corporation (HAE) - Investire in azioni Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"pl_PL":{"locale":"pl_PL","id":355777,"slug":"how-to-buy-haemonetics-corporation","post_title":"Jak kupi\u0107 akcje Haemonetics Corporation (HAE) - Inwestycja w akcje Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"es_ES":{"locale":"es_ES","id":355778,"slug":"how-to-buy-haemonetics-corporation","post_title":"C\u00f3mo comprar acciones de Haemonetics Corporation (HAE) - Inversi\u00f3n en acciones de Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"th_TH":{"locale":"th_TH","id":355783,"slug":"how-to-buy-haemonetics-corporation","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Haemonetics Corporation (HAE) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"tr_TR":{"locale":"tr_TR","id":355779,"slug":"how-to-buy-haemonetics-corporation","post_title":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"vt_VT":{"locale":"vt_VT","id":355782,"slug":"how-to-buy-haemonetics-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Haemonetics Corporation (HAE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"pt_AA":{"locale":"pt_AA","id":355776,"slug":"how-to-buy-haemonetics-corporation","post_title":"Como comprar a\u00e7\u00f5es da Haemonetics Corporation (HAE) - Investimento em a\u00e7\u00f5es da Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/355772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=355772"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/355772\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=355772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=355772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=355772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}